These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28154318)

  • 1. [Pharmaceutical Sciences Advancing Molecular Cancer Therapeutics～To Improve Rationale and Effectiveness of Molecularly Targeted Drugs～].
    Noguchi K; Mashima T
    Yakugaku Zasshi; 2017; 137(2):127-128. PubMed ID: 28154318
    [No Abstract]   [Full Text] [Related]  

  • 2. [Translational research - towards personalized medicine].
    Tokui T
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):122-5. PubMed ID: 23470475
    [No Abstract]   [Full Text] [Related]  

  • 3. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Innovative approach for drug discovery by targeted therapy].
    Kikuchi H; Kato K
    Yakugaku Zasshi; 2013; 133(1):41-2. PubMed ID: 23292018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Life-oriented Chemistry in Pharmaceutical Sciences].
    Kawaguchi M; Taniguchi A
    Yakugaku Zasshi; 2019; 139(2):261-262. PubMed ID: 30713237
    [No Abstract]   [Full Text] [Related]  

  • 8. Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing.
    Hafez N; Walther Z; Eder JP; Sklar JL; Gettinger SN; Finberg KE; Goldberg SB
    Lancet Oncol; 2020 Mar; 21(3):343-344. PubMed ID: 32950226
    [No Abstract]   [Full Text] [Related]  

  • 9. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RACE to accelerate drug development for children with cancer.
    Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumour-agnostic therapies.
    Looney AM; Nawaz K; Webster RM
    Nat Rev Drug Discov; 2020 Jun; 19(6):383-384. PubMed ID: 32494047
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges ahead for companion diagnostics.
    Schmidt C
    J Natl Cancer Inst; 2012 Jan; 104(1):14-5. PubMed ID: 22173588
    [No Abstract]   [Full Text] [Related]  

  • 13. Health: Make precision medicine work for cancer care.
    Rubin MA
    Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chamical Biology for Pharmaceutical Sciences-Novel Approaches for Exploring Cellular Functions with Non-drug Chemicals].
    Ojida A; Nakagawa H
    Yakugaku Zasshi; 2016; 136(1):1. PubMed ID: 26725659
    [No Abstract]   [Full Text] [Related]  

  • 15. Translational research in oncology--10 years of progress and future prospects.
    Doroshow JH; Kummar S
    Nat Rev Clin Oncol; 2014 Nov; 11(11):649-62. PubMed ID: 25286976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy of Daiichi Sankyo discovery research in oncology.
    Akahane K; Hirokawa K
    Jpn J Clin Oncol; 2014 Feb; 44(2):109-15. PubMed ID: 24459194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-5.
    Mangoni AA; Eynde JJV; Jampilek J; Hadjipavlou-Litina D; Liu H; Reynisson J; Sousa ME; Gomes PAC; Prokai-Tatrai K; Tuccinardi T; Sabatier JM; Luque FJ; Rautio J; Karaman R; Vasconcelos MH; Gemma S; Galdiero S; Hulme C; Collina S; Gütschow M; Kokotos G; Siciliano C; Capasso R; Agrofoglio LA; Ragno R; Muñoz-Torrero D
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31262039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 19. How Targeted Therapies Are Changing Treatment for Non-Small Cell Lung Cancer.
    Becze E
    ONS Connect; 2016 Feb; 31(2):24-5. PubMed ID: 26930998
    [No Abstract]   [Full Text] [Related]  

  • 20. A Precision Medicine Approach to Clinical Trials.
    Rubin R
    JAMA; 2016 Nov; 316(19):1953-1955. PubMed ID: 27760248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.